• 한국의학물리학회지:의학물리
• /
• 제28권4호
• /
• pp.181-189
• /
• 2017

The conventional delivery quality assurance (DQA) process for RapidArc (Varian Medical Systems, Palo Alto, USA), has the limitation that it measures and analyzes the dose in a phantom material and cannot analyze the dosimetric changes under the motional organ condition. In this study, a DQA method was designed to overcome the limitations of the conventional DQA process for internal target volume (ITV) based RapidArc. The dynamic DQA measurement device was designed with a moving phantom that can simulate variable target motions. The dose distribution in the real volume of the target and organ-at-risk (OAR)s were reconstructed using 3DVH with the ArcCHECK (SunNuclear, Melbourne, USA) measurement data under the dynamic condition. A total of 10 ITV-based RapidArc plans for liver-cancer patients were analyzed with the designed dynamic DQA process. The average pass rate of gamma evaluation was $81.55{\pm}9.48%$ when the DQA dose was measured in the respiratory moving condition of the patient. Appropriate method was applied to correct the effect of moving phantom structures in the dose calculation, and DVH data of the real volume of target and OARs were created with the recalculated dose by the 3DVH program. We confirmed the valid dose coverage of a real target volume in the ITV-based RapidArc. The variable difference of the DVH of the OARs showed that dose variation can occur differently according to the location, shape, size and motion range of the target. The DQA process devised in this study can effectively evaluate the DVH of the real volume of the target and OARs in a respiratory moving condition in addition to the simple verification of the accuracy of the treatment machine. This can be helpful to predict the prognosis of treatment by the accurate dose analysis in the real target and OARs.

• 대한방사선기술학회지:방사선기술과학
• /
• 제39권3호
• /
• pp.391-397
• /
• 2016

저병기 폐암은 정위적 체부 방사선치료 방식이 높은 효과를 나타내지만, 호흡에 의한 움직임으로 인해 정확한 선량의 조사가 쉽지 않다. 이에 본 연구는 움직이는 표적을 대상으로 영상획득 방식에 따른 체적을 분석하고, 체적 설정방식 및 호흡주기에 따른 선량을 유리선량계를 이용하여 평가하였다. 그 결과, 체적 획득의 경우 4D CT가 $10.4cm^3$로 실제 체적인 $12.3cm^3$에 가장 근접한 결과를 나타냈다. 선량평가에서는 ITV가 처방선량 10, 15, 20 Gy에서 각각 10.82, 16.88, 21.90 Gy로 가장 높은 값을 보였으며, RGRT가 좀 더 높은 값을 나타내었으나 호흡주기에 따른 결과는 유의한 차이를 나타내지 않았다. 따라서 움직이는 종양의 치료 시 4D CT를 이용하여 영상을 획득 후 ITV를 설정하여 RGRT방식으로 치료하는 것이 유리할 것으로 사료된다.

• Radiation Oncology Journal
• /
• 제38권1호
• /
• pp.18-25
• /
• 2020

Purpose: This study was aim to evaluate the patterns of failure according to radiotherapy (RT) target volume for cervical lymph nodes in metastases of unknown primary origin in head and neck region (HNMUO). Materials and Methods: Sixty-two patients with HNMUO between 1998 and 2016 were retrospectively reviewed. We analyzed the clinical outcomes and primary site failure depending on the radiation target volume. The target volume was classified according to whether the potential head and neck mucosal sites were included and whether the neck node was treated involved side only or bilaterally. Results: Potential mucosal site RT (mucosal RT) was done to 23 patients and 39 patients did not receive mucosal RT. Mucosal RT showed no significant effect on overall survival (OS) and locoregional recurrence (LRR). The location of primary site failure encountered during follow-up period was found to be unpredictable and 75% of patients with recurrence received successful salvage therapies. No significant differences in OS and LRR were found between patients treated to unilateral (n = 35) and bilateral neck irradiation (n = 21). Treatment of both necks resulted in significantly higher mucositis. Conclusions: We found no advantages in OS and LRR of patients with HNMUO when mucosal sites and bilateral neck node were included in the radiation target volume.

• Radiation Oncology Journal
• /
• 제31권4호
• /
• pp.247-251
• /
• 2013

Purpose: This study aimed to investigate efficient approaches for determining internal target volume (ITV) from four-dimensional computed tomography (4D CT) images used in stereotactic body radiotherapy (SBRT) for patients with early-stage non-small cell lung cancer (NSCLC). Materials and Methods: 4D CT images were analyzed for 15 patients who received SBRT for stage I NSCLC. Three different ITVs were determined as follows: combining clinical target volume (CTV) from all 10 respiratory phases ($ITV_{10Phases}$); combining CTV from four respiratory phases, including two extreme phases (0% and 50%) plus two intermediate phases (20% and 70%) ($ITV_{4Phases}$); and combining CTV from two extreme phases ($ITV_{2Phases}$). The matching index (MI) of $ITV_{4Phases}$ and $ITV_{2Phases}$ was defined as the ratio of $ITV_{4Phases}$ and $ITV_{2Phases}$, respectively, to the $ITV_{10Phases}$. The tumor motion index (TMI) was defined as the ratio of $ITV_{10Phases}$ to $CTV_{mean}$, which was the mean of 10 CTVs delineated on 10 respiratory phases. Results: The ITVs were significantly different in the order of $ITV_{10Phases}$, $ITV_{4Phases}$, and $ITV_{2Phases}$ (all p < 0.05). The MI of $ITV_{4Phases}$ was significantly higher than that of $ITV_{2Phases}$ (p < 0.001). The MI of $ITV_{4Phases}$ was inversely related to TMI (r = -0.569, p = 0.034). In a subgroup with low TMI (n = 7), $ITV_{4Phases}$ was not statistically different from $ITV_{10Phases}$ (p = 0.192) and its MI was significantly higher than that of $ITV_{2Phases}$ (p = 0.016). Conclusion: The $ITV_{4Phases}$ may be an efficient approach alternative to optimal $ITV_{10Phases}$ in SBRT for early-stage NSCLC with less tumor motion.

• 한국콘텐츠학회논문지
• /
• 제15권8호
• /
• pp.416-423
• /
• 2015

본 연구에서는 내부표적체적을 통한 방사선치료계획을 분석하여 호흡연동방사선치료에 주로 이용되는 호기상태의 치료계획체적과 비교 분석하여 정상조직이 받은 선량을 알아보았다. 2013년 12월부터 2014년 6월까지 모 대학교병원 방사선종양학과에서 복부부위에 호흡연동방사선치료를 받은 환자 25명을 대상으로 하였으며, 암의 종류는 liver(64%), CBD(8%), gastric(8%), GB(8%), pancreas(8%), SMA(4%)이었다. ITV와 PTV 체적의 평균치는 $471.44cm^3$, $425.48cm^3$ 로 체적의 증가를 알 수 있었고, PTV구간에서 ITV구간으로 선택한 구간의 증가로 인해 정상조직체적 또한 증가함을 알 수 있었다. 그리고 정상조직체적의 증가, target volume 증가, 치료조사야 면적증가의 차이와 정상조직이 받은 선량평균치의 차이에서는 right kidney가 유의한 증가를 보였다. 호흡평균치에 따른 정상조직이 받은 선량평균치의 차이는 없었고 target moving과 정상조직의 선량평균치의 차이에서는 both kidney가 유의한 차이를 나타내었다. 결론적으로 PTV구간과 ITV구간 체적 설정을 통한 치료방법이 모두 정상조직의 보호선량에 적합하였으며, 처방선량의 95% 이상이 분포하였으므로 환자의 치료목적에 따라 선택적으로 사용되어도 무방할 것이라 사료된다.

• 한국의학물리학회지:의학물리
• /
• 제28권4호
• /
• pp.164-170
• /
• 2017

One of the methods to consider the effect of respiratory motion of a tumor target in radiotherapy is to establish a treatment plan with the internal target volume (ITV) created based on an accurate analysis of the target motion displacement. When this method is applied to intensity modulated radiotherapy (IMRT), it is expected to yield a different treatment dose distribution under the motion condition according to the IMRT method. In this study, we prepared ITV-based IMRT plans with conventional IMRT using fixed gantry angle beams, RapidArc using volumetric modulated arc therapy, and tomotherapy using helical therapy. Then, the variation in dose distribution caused by the target motion was analyzed by the dose measurement in the actual motion condition. A delivery quality assurance plan was prepared for the established IMRT plan and the dose distribution in the actual motion condition was measured and analyzed using a two-dimensional diode detector placed on a moving phantom capable of simulating breathing movements. The dose measurement was performed considering only a uniform target shape and motion in the superior-inferior (SI) direction. In this condition, it was confirmed that the error of the dose distribution due to the target motion is minimum in tomotherapy. This is thought to be due to the characteristic of tomotherapy that treats the target sequentially by dividing it into several slices. When the target shape is uniform and the main target motion direction is SI, it is considered that tomotherapy for the ITV-based IMRT method has a characteristic which can reduce the dose difference compared with the plan dose under the target motion condition.

• Radiation Oncology Journal
• /
• 제35권2호
• /
• pp.180-184
• /
• 2017

Patients with locally advanced lung cancer and very limited pulmonary function (forced expiratory volume in 1 second $[FEV1]{\leq}1L$) have dismal prognosis and undergo palliative treatment or best supportive care. We describe two cases of locally advanced node-positive non-small cell lung cancer (NSCLC) patients with very limited lung function treated with induction chemotherapy and moderate hypofractionated image-guided radiotherapy (Hypo-IGRT). Hypo-IGRT was delivered to a total dose of 45 Gy to the primary tumor and involved lymph nodes. Planning was based on positron emission tomography-computed tomography (PET/CT) and four-dimensional computed tomography (4D-CT). Internal target volume (ITV) was defined as the overlap of gross tumor volume delineated on 10 phases of 4D-CT. ITV to planning target volume margin was 5 mm in all directions. Both patients showed good clinical and radiological response. No relevant toxicity was documented. Hypo-IGRT is feasible treatment option in locally advanced node-positive NSCLC patients with very limited lung function ($FEV1{\leq}1L$).

• 한국의학물리학회지:의학물리
• /
• 제24권4호
• /
• pp.220-229
• /
• 2013

Respiratory-induced dynamic tumors render free-breathing cone-beam computed tomography (FBCBCT) images with motion artifacts complicating the task of quantifying the internal target volume (ITV). The purpose of this paper is to study the visibility of the revealed ITV when the imaging dose parameters, such as the kVp and mAs, are varied. The $Trilogy^{TM}$ linear accelerator with an On-Board Imaging ($OBI^{TM}$) system was used to acquire low-imaging-dose-mode (LIDM: 110 kVp, 20 mA, 20 ms/frame) and high-imaging-dose-mode (HIDM: 125 kVp, 80 mA, 25 ms/frame) FBCBCT images of a 3-cm diameter sphere (density=0.855 $g/cm^3$) moving in accordance to various sinusoidal breathing patterns, each with an unique inhalation-to-exhalation (I/E) ratio, amplitude, and period. In terms of image ITV contrast, there was a small overall average change of the ITV contrast when going from HIDM to LIDM of $6.5{\pm}5.1%$ for all breathing patterns. As for the ITV visible volume measurements, there was an insignificant difference between the ITV of both the LIDM- and HIDM-FBCBCT images with an average difference of $0.5{\pm}0.5%$, for all cases, despite the large difference in the imaging dose (approximately five-fold difference of ~0.8 and 4 cGy/scan). That indicates that the ITV visibility is not very sensitive to changes in imaging dose. However, both of the FBCBCT consistently underestimated the true ITV dimensions by up to 34.8% irrespective of the imaging dose mode due to significant motion artifacts, and thus, this imaging technique is not adequate to accurately visualize the ITV for image guidance. Due to the insignificant impact of imaging dose on ITV visibility, a plausible, alternative strategy would be to acquire more X-ray projections at the LIDM setting to allow 4DCBCT imaging to better define the ITV, and at the same time, maintain a reasonable imaging dose, i.e., comparable to a single HIDM-FBCBCT scan.

• 혜화의학회지
• /
• 제10권1호
• /
• pp.157-166
• /
• 2001

Oryoungsan which first recorded in Sanghanron, the clinical medical book consists of treating acute febrile disease according to its change, is one of the frequently used oriental medicines. these days, it has been prescribed in symptoms accompanied by edema mostly. therefore it is easy to consider it as a type of diuretics. In Sanghanron it was originally used in the symptoms of perspiration, decreased urine volume, thirsty, flatulence. these symptoms indicate loss of body fluid and the prescription which orders "taking warm water sufficiently" supports this. On this background, it is supposed that Oryoungsan treats dehydration after providing water and electrolytes. To consider that herbal medicines consisted of Oryoungsan make electrolytes go out of the body, The healing mechanism of dehydration doesn't meet this. Because Oryoungsan was used in condition of fever or in similar condition, it is more resonable to understand that restoration of increasing blood flow to the subcutaneous venous plexus regulating body temperature in febrile condition into body circulation, resulting into maintaining main blood volume and into treating decreased urine volume and thirsty is Oryoungsan's function in the dehydration or febrile condition. That is, symptoms are decreased or disappeared through restoring unbalance of internal body fluid. The other target is pain controls, especially chronic headache, facial pain and trigeminal neuralgia. it is suggested that the function of pain control of Oryoungsan is related to 5-HT(5-hydroxytrypamine), nerve transmitter in the endogenous analgesic system. Moreover it is also suggested that Oryoungsan is relate to 5-HT, considering the fact that gastroparesis, a symptom of cyclic vomiting syndrome treated with 5-HT1D receptor agonist is similar to the 'bi', symptoms appeared in the Oryoungsan-related disease.

• 대한방사선치료학회지
• /
• 제22권2호
• /
• pp.145-153
• /
• 2010

목 적: 움직이는 종양의 방사선치료에서 종양의 크기와 호흡에 따른 움직임을 고려한 ITV를 정확하게 결정하기 위하여 나선형 전산화 단층촬영(helical CT)과 호흡동기 전산화 단층촬영(4D CT)으로부터 획득한 영상에 나타난 표적의 용적을 정량적으로 분석하였다. 대상 및 방법: 지름이 1.5 cm, 3 cm, 6 cm인 아크릴 구를 상 하위로 움직이는 팬텀에 위치하고 LightSpeed $RT^{16}$ CT simulator를 이용하여 영상을 획득하였다. 종양의 움직임에 따른 표적의 정확한 묘사에 대한 영향을 평가하기 위하여 1~4 cm로 종양이 움직이고, 그 호흡주기가 3∼6초인 경우로 설정하여 MIP 영상을 얻어 표적 용적을 비율로써 분석하였다. 결 과: 1.5 cm, 3 cm, 6 cm 표적의 Ratio$_{helical}$은 각각 $32{\pm}14%$, $45{\pm}14%$, $58{\pm}13%$로 나타났고 4D CT로 얻은 Ratio$_{MIP}$는 각각 $98{\pm}8%$, $97{\pm}5%$, $95{\pm}1%$였다. 결 론: 4D CT의 MIP 영상에 묘사된 표적의 체적은 helical CT에서 얻은 체적과 비교할 때 그 궤적을 잘 반영해 주었다. 비록 작고 움직임이 큰 표적은, 예를 들어 1.5 cm 지름의 표적이 4 cm의 거리를 움직일 때, 예상되는 체적의 86%를 나타내어 실제보다 체적이 적게 평가될 수 있었으며, 다른 조건에서는 표적의 크기나 호흡에 의한 움직임에 대하여 체적의 $97.1{\pm}4.4%$를 반영했다. 특히 크기가 작아 신중한 주의를 요하는 초기 병기의 종양에 대하여, 호흡에 의한 움직임이 크고 호흡이 불안정한 경우에 MIP 영상을 이용하여 표적의 체적을 나타내는 것이 적절하다고 사료된다.